TORONTO, Sept. 27 /CNW/ - Spectral Diagnostics Inc. (TSX:SDI) today announced the co-sponsorship with Toray Medical Company (Tokyo, Japan) of a key scientific session at SEPSIS 2007, an International Symposium held at the Institut Pasteur in Paris, France from September 26-29th, 2007. “Endotoxemia - Detection, Consequence and Intervention” will feature a panel of four thought leaders in the field of sepsis discussing the value of Spectral’s EAA(TM) Endotoxin Activity Assay. The EAA(TM) is the only FDA cleared, whole blood assay for the detection of endotoxemia.
